For example, molecular approaches to tumor profiling have revolutionized the characterization of endometrial cancers, which can now be classified according to DNA polymerase epsilon (POLE) mutation status, MSI status, and the number of somatic copy number alterations [77,78]. The gene discussed is POLE; the disease is neoplasm.